Cargando…
Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment
Therapeutic treatment of severe COVID-19 infection involves the administration of multiple pharmacologic agents to reduce the risk of serious complications; this may result in drug interactions and possible adverse reactions and induced cardiotoxicity. The risk–benefit ratio associated with the use...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600338/ https://www.ncbi.nlm.nih.gov/pubmed/34792677 http://dx.doi.org/10.1186/s43044-021-00228-8 |